PQS Trend Report Examines Socio-Demographic and Utilization Factors Related to Medication Adherence

DURHAM, NC / ACCESSWIRE / December 4, 2023 / Pharmacy Quality Solutions (PQS), a leading provider of performance management services, released its 2023 Industry Trend Report in Pharmacy Quality. This year’s report underscores the impact that socio-demographic factors could have on performance, further supporting the need for tailored patient solutions utilizing pharmacy to drive positive changes.

PQS Logo
Pharmacy Quality Solutions, Inc.

The Trend Report aims to provide stakeholders with evolving trends in quality for medication use. Through detailed data analysis, PQS provides insights to support informed decision making within the healthcare sector and delivery of performance strategies. This year’s trend report examines the influence of socio-demographic and utilization factors on medication adherence measure rates, offering valuable insights for healthcare industry stakeholders seeking to enhance medication quality strategies using pharmacy claims data.

In the first chapter, the trend report focuses on the impact of socio-demographic factors, including age, gender, and low-income subsidy (LIS) status, on adherence rates for Cholesterol, Diabetes, and Renin Angiotensin System Antagonists (RASA) Proportion of Days Covered (PDC) measures.

Andrew Thorne, Director of Analytics and Program Development at PQS, highlights that across all three PDC measures, performance tends to be slightly lower for patients who are eligible for low-income subsidy. Thorne notes, “Our findings suggest that economic status may have a more pronounced impact than variables such as age and gender.”

The next chapter of the report highlights how adherence can be impacted by factors such as drug switching within a measurement year and the utilization of extended fills. Extended fill utilization had the most noteworthy difference for the Diabetes PDC measure, where there is a performance rate difference exceeding 20% between extended fill and only non-extended fill scenarios.

Beyond these insights, the 2023 Trend Report underscores the importance of medication adherence and the methods used for its measurement. By presenting a review of the performance differences in medication adherence, PQS aims to empower quality stakeholders and advocates with the knowledge to enhance medication quality and ultimately, patient health outcomes.

To download the trend report to access the full insights, please visit https://www.pharmacyquality.com.

About Pharmacy Quality Solutions, Inc. (PQS)

PQS aligns healthcare payers and pharmacies to achieve their shared goals of better patient outcomes and healthcare quality performance. As a neutral, trusted intermediary supporting the evolution of value-based care, PQS facilitates nationwide pharmacy-based care through our partners and the EQUIPP® platform. Utilizing deep clinical pharmacy knowledge and over a decade of performance management experience, PQS helps clients develop strategies, implement quality improvement programs, and optimize the quality of healthcare for their Medicare, Medicaid, and commercial populations. For more information on how PQS can support you, please visit www.pharmacyquality.com.

Contact Information

David Simoneaux
Senior Communications Specialist
dsimoneaux@pharmacyquality.com
919.767.9544

SOURCE: Pharmacy Quality Solutions, Inc.

View source version on accesswire.com:
https://www.accesswire.com/812890/pqs-trend-report-examines-socio-demographic-and-utilization-factors-related-to-medication-adherence

Staff

Recent Posts

Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods

Milestone enables GMP manufacturing to accelerate clinical trials and transform global vaccine delivery BRISBANE, Australia…

15 hours ago

InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial

BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading…

15 hours ago

President Trump’s Cannabis Decision Is Coming – And Why MMJ International Holdings Wins Either Way

12 Month Timeline - How Cannabis Rescheduling Actually Takes EffectAnnouncementPresident signals intent or issues executive…

1 day ago

Accelerating Patient Recruitment and Research Excellence: TrialWire® Supports Endpoints Clinical Trials Day NYC 2025

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…

2 days ago

Genesis Healthcare Remains Committed to Securing Longterm Stability

The skilled nursing, assisted and senior living provider reiterates dedication to a financial restructuring process…

2 days ago